| For: | Dragutinović VV, Radovanović NS, Izrael-Živković LT, Vrvić MM. Detection of gelatinase B activity in serum of gastric cancer patients. World J Gastroenterol 2006; 12(1): 105-109 [PMID: 16440426 DOI: 10.3748/wjg.v12.i1.105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i1/105.htm |
| Number | Citing Articles |
| 1 |
Kyle J. Isaacson, M. Martin Jensen, Nithya B. Subrahmanyam, Hamidreza Ghandehari. Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. Journal of Controlled Release 2017; 259 doi: 10.1016/j.jconrel.2017.01.034
|
| 2 |
SU-ZUAN CHEN, HUAI-QI YAO, SEN-ZHI ZHU, QIU-YUAN LI, GUANG-HUA GUO, JING YU. Expression levels of matrix metalloproteinase-9 in human gastric carcinoma. Oncology Letters 2015; 9(2) doi: 10.3892/ol.2014.2768
|
| 3 |
Sona Krizkova, Ondrej Zitka, Vojtech Adam, Rene Kizek, Michal Masarik, Marie Stiborova, Tomas Eckschlager, Grace J. Chavis. Assays for determination of matrix metalloproteinases and their activity. TrAC Trends in Analytical Chemistry 2011; 30(11) doi: 10.1016/j.trac.2011.06.016
|
| 4 |
Sol de la Peña, Clara L. Sampieri, Kenneth León-Córdoba. Metaloproteasas de la matriz extracelular como marcadores moleculares en cáncer gástrico. Medicina Clínica 2010; 134(3) doi: 10.1016/j.medcli.2009.09.031
|
| 5 |
André Jefremow, Markus F. Neurath. Nanoparticles in Gastrooncology. Visceral Medicine 2020; 36(2) doi: 10.1159/000506908
|
| 6 |
Ram Sarup Singh, Taranjeet Singh, Ashish Kumar Singh. Advances in Enzyme Technology. 2019; doi: 10.1016/B978-0-444-64114-4.00009-1
|
| 7 |
Nilanjan Adhikari, Sk. Abdul Amin, Tarun Jha. Cancer-Leading Proteases. 2020; doi: 10.1016/B978-0-12-818168-3.00010-3
|
| 8 |
Nina E. Lamash, Igor Yu Dolmatov, A. Aziz Aboobaker. Proteases from the Regenerating Gut of the Holothurian Eupentacta fraudatrix. PLoS ONE 2013; 8(3) doi: 10.1371/journal.pone.0058433
|
| 9 |
Subha Mondal, Nilanjan Adhikari, Suvankar Banerjee, Sk Abdul Amin, Tarun Jha. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. European Journal of Medicinal Chemistry 2020; 194 doi: 10.1016/j.ejmech.2020.112260
|
| 10 |
Yukihiro Nomura, Kunika Takasaki, Masakazu Tada, Masataka Yoshimoto, Hideyuki Ishida, Nobuo Murata, Shunichiro Kubota. Pro-MMP-9 is associated with poor prognosis in gastric cancer. Scandinavian Journal of Gastroenterology 2007; 42(9) doi: 10.1080/00365520701435881
|
| 11 |
Nahla E. El-Ashmawy, Naglaa F. Khedr, Mohamed G. Mansour, Ghada M. Al-Ashmawy. TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1. Clinical and Experimental Medicine 2020; 20(4) doi: 10.1007/s10238-020-00651-2
|
| 12 |
Milica Velimirović, Gordana Jevtić Dožudić, Vesna Selaković, Tihomir Stojković, Nela Puškaš, Ivan Zaletel, Milica Živković, Vesna Dragutinović, Tatjana Nikolić, Ankica Jelenković, Djordje Djorović, Aleksandar Mirčić, Nataša D. Petronijević, Walid Rachidi. Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/3273654
|
| 13 |
Zainab Ahmed Rashid, Sanaa K. Bardaweel. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. International Journal of Molecular Sciences 2023; 24(15) doi: 10.3390/ijms241512133
|
| 14 |
Kaisheng Yuan, Di Hu, Xiaocong Mo, Ruiqi Zeng, Bing Wu, Zunhao Zhang, Ruixiang Hu, Cunchuan Wang. Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation. Aging 2023; 15(17) doi: 10.18632/aging.204993
|
| 15 |
Marta Łukaszewicz-Zając, Barbara Mroczko, Maciej Szmitkowski. Gastric cancer — The role of matrix metalloproteinases in tumor progression. Clinica Chimica Acta 2011; 412(19-20) doi: 10.1016/j.cca.2011.06.003
|
| 16 |
Il-Sup Kim, Woong-Suk Yang, Cheorl-Ho Kim. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase
Inhibitors in Inflammation-Mediated Human Diseases. Current Medicinal Chemistry 2023; 30(18) doi: 10.2174/0929867329666220823112731
|
| 17 |
Chun-Ying Wu, Ming-Shiang Wu, En-Pei Chiang, Yi-Ju Chen, Chien-Jen Chen, Nai-Hui Chi, Ying-Ting Shih, Gran-Hum Chen, Jaw-Town Lin. Plasma Matrix Metalloproteinase-9 Level Is Better than Serum Matrix Metalloproteinase-9 Level to Predict Gastric Cancer Evolution. Clinical Cancer Research 2007; 13(7) doi: 10.1158/1078-0432.CCR-06-2299
|
| 18 |
Oi Lian Kon, Tai-Tung Yip, Meng Fatt Ho, Weng Hoong Chan, Wai Keong Wong, Soo Yong Tan, Wai Har Ng, Siok Yuen Kam, Alvin KH Eng, Patrick Ho, Rosa Viner, Hock Soo Ong, M Priyanthi Kumarasinghe. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Medical Genomics 2008; 1(1) doi: 10.1186/1755-8794-1-54
|
| 19 |
Hsi‐Feng Tu, Cheng‐Hsien Wu, Shou‐Yen Kao, Chung‐Ji Liu, Tsung‐Yun Liu, Man‐Tin Lui. Functional −1562 C‐to‐T polymorphism in matrix metalloproteinase‐9 (MMP‐9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Journal of Oral Pathology & Medicine 2007; 36(7) doi: 10.1111/j.1600-0714.2007.00552.x
|
| 20 |
Yanfei Lang, Xiurui Han, Xin Liu, Jing Ning, Xinyu Hao, Hejun Zhang, Jing Zhang, Kangle Zhai, Jing Zhang, Weiwei Fu, Shigang Ding. Cmtm4 Deficiency Inhibits Helicobacter pylori‐Induced Gastric Carcinogenesis. Pathology International 2025; 75(6) doi: 10.1111/pin.70020
|
| 21 |
Rutian Li, Baorui Liu, Jiahui Gao. The application of nanoparticles in diagnosis and theranostics of gastric cancer. Cancer Letters 2017; 386 doi: 10.1016/j.canlet.2016.10.032
|